Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -51.179% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) Clc1ccc(Cn2ncc3c(NCc4cccnc4)ncnc32)cc1
b.) O=C(CNC(=O)c1ccc(Br)o1)Nc1cccc(-c2cnc3ccccc3n2)c1
c.) Cc1ccc(OCCNC(=O)C2CC(=O)N(c3ccc(C)cc3)C2)cc1
d.) Cc1ccc(C)c(N2CCN(CCCNC(=O)Cn3cc4c(n3)CCC(C)C4)CC2)c1
e.) O=C(Nc1ccccc1)N(Cc1ccccc1)CC(O)C(F)(F)F
Answer: a. Clc1ccc(Cn2ncc3c(NCc4cccnc4)ncnc32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc(Cn2ncc3c(NCc4cccnc4)ncnc32)cc1
Clc1ccc(Cn2ncc3c(NCc4cccnc4)ncnc32)cc1
1-[(4-chlorophenyl)methyl]-N-(pyridin-3-ylmethyl)pyrazolo[3,4-d]pyrimidin-4-amine